pSivida Moving Forward With Late-Stage Eye Drug

Massachusetts drug developer pSivida is ready to move its latest eye drug/device combo to the next stage now that Phase III results show overwhelming efficacy.

The results from a late-stage study of Medidur were announced on Dec. 22, showing the implant was more effective than...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Archive

More from Scrip